Shares of Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) traded up 8.2% during trading on Wednesday . The stock traded as high as $47.35 and last traded at $47.25. 341,783 shares changed hands during trading, a decline of 45% from the average session volume of 622,976 shares. The stock had previously closed at $43.65.
Wall Street Analysts Forecast Growth
A number of brokerages have recently issued reports on TRUP. Northland Securities upped their price objective on shares of Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research note on Thursday, October 31st. Stifel Nicolaus upped their price target on shares of Trupanion from $42.00 to $44.00 and gave the company a “hold” rating in a research report on Monday, January 6th. Bank of America lifted their price objective on Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a report on Friday, September 20th. Finally, Piper Sandler increased their target price on Trupanion from $45.00 to $57.00 and gave the company a “neutral” rating in a report on Thursday, October 31st. Three investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $45.33.
Read Our Latest Stock Report on TRUP
Trupanion Trading Down 1.8 %
Trupanion (NASDAQ:TRUP – Get Free Report) last announced its earnings results on Wednesday, October 30th. The financial services provider reported $0.03 EPS for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.09. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The company had revenue of $327.50 million during the quarter, compared to the consensus estimate of $321.79 million. During the same quarter in the prior year, the company earned ($0.10) earnings per share. The firm’s revenue for the quarter was up 14.6% on a year-over-year basis. Sell-side analysts anticipate that Trupanion, Inc. will post -0.2 earnings per share for the current year.
Insider Activity
In related news, Director Murray B. Low sold 2,000 shares of Trupanion stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $52.67, for a total transaction of $105,340.00. Following the sale, the director now directly owns 131,513 shares in the company, valued at $6,926,789.71. The trade was a 1.50 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Steve Weinrauch sold 11,916 shares of the company’s stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $53.00, for a total value of $631,548.00. Following the completion of the sale, the executive vice president now directly owns 48,978 shares in the company, valued at approximately $2,595,834. The trade was a 19.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 28,597 shares of company stock valued at $1,522,082. Corporate insiders own 5.50% of the company’s stock.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of TRUP. Quest Partners LLC purchased a new stake in Trupanion in the third quarter worth about $37,000. Wilmington Savings Fund Society FSB bought a new position in Trupanion during the 3rd quarter valued at approximately $54,000. GAMMA Investing LLC increased its position in Trupanion by 70.4% during the 3rd quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock valued at $61,000 after buying an additional 596 shares in the last quarter. Entropy Technologies LP purchased a new position in Trupanion during the third quarter valued at $202,000. Finally, Mutual of America Capital Management LLC bought a new stake in Trupanion in the third quarter worth $210,000.
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Articles
- Five stocks we like better than Trupanion
- Comparing and Trading High PE Ratio Stocks
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- What is the S&P 500 and How It is Distinct from Other Indexes
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- Investing in Construction Stocks
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.